Jinping Cai

机构：Huazhong Agricultural University

发表论文 31 篇 · 总被引 573 次 · h-index 11

代表论文

• Lenvatinib plus anti-PD-1 antibodies as conversion therapy for patients with unresectable intermediate-advanced hepatocellular carcinoma: a single-arm, phase II trial (2023 · Journal for ImmunoTherapy of Cancer · 被引 131)
• Efficacy and predictive biomarkers of immunotherapy in Epstein-Barr virus-associated gastric cancer (2022 · Journal for ImmunoTherapy of Cancer · 被引 106)
• Mutations of PI3K-AKT-mTOR pathway as predictors for immune cell infiltration and immunotherapy efficacy in dMMR/MSI-H gastric adenocarcinoma (2022 · BMC Medicine · 被引 89)
• Investigation into the alkali-activation of lithium slag: A sustainable alternative to conventional cement with optimized mechanical properties (2024 · Construction and Building Materials · 被引 47)
• Combination of AKT1 and CDH1 mutations predicts primary resistance to immunotherapy in dMMR/MSI-H gastrointestinal cancer (2022 · Journal for ImmunoTherapy of Cancer · 被引 40)
• Plasma-only circulating tumor DNA analysis detects minimal residual disease and predicts early relapse in hepatocellular carcinoma patients undergoing curative resection (2023 · Frontiers in Oncology · 被引 28)